Sandra Cottrell

Sandra Cottrell has a long and varied work experience in the field of Regulatory Affairs. Sandra began their career in 2000 as an Adjunct Professor at Temple University's School of Pharmacy QA/RA. In 2002, they became Global VP of Reg Aff at INO Therapeutics and then Vice President at B&H Consulting Services in 2006. From 2006 to 2009, they were Vice President of Regulatory Affairs at NPS Pharmaceuticals. In 2009, they moved to Novo Nordisk, Inc. as Therapeutic Area Head, Sr Dir Reg Aff. From 2013 to 2014, they were Vice President of Regulatory Affairs at Mylan Specialty. In 2014, they became President of Regulatory Gap Services, LLC and in 2015, they were Head of Regulatory Affairs at Chugai Pharma USA. Finally, in 2018, they became Head of Regulatory Strategy at B&H Consulting Services, Inc.

Sandra Cottrell attended Temple University from 1985 to 1992 and obtained a PhD, MA, and BA in Pharmaceutics (emphasis in Reg Aff) and Chemistry.